About Niowave
Niowave is a Healthcare company based in United States founded in 2006. Devices and radioisotopes for nuclear imaging are provided by Niowave. Niowave has raised $9.95 million across 21 funding rounds from investors including SBIR and OSTI.GOV. Its chief executive, as recorded, is Mike Zamiara. Its focus areas include Life Sciences, Imaging Diagnostics, Nuclear Imaging and Life Sciences Platforms and Tools. Its competitors include NorthStar Medical Radioisotopes, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY; 2 of its 3 listed competitors have raised funding.
Company details
Niowave was founded in 2006 in the United States and operates within the medical diagnostics and research sector. Superconducting electron linear accelerators, medical radioisotopes, high-power X-ray sources, and high-flux neutron sources are produced by the company. These products support nuclear imaging applications and related research activities across the industry.
- Headquarters United States
- SectorsHealthcare
- Website niowaveinc.com
- Social LinkedIn
- Total Equity Funding$9.95M (USD)
in 21 rounds
- Latest Funding Round$1.95M (USD), Series A
Dec 2021
- InvestorsSBIR
& 1 more
Funding Insights of Niowave
Niowave has successfully raised a total of $9.95M across 21 strategic funding rounds. The most recent funding activity was a Series A round of $1.95 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.95M
- Total Rounds 21
- Last Round Series A — $1.95M
- First Round $1.07M
(Aug 2007)
- Investors Count 2
Latest 10 of 21 funding rounds of Niowave with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Niowave
Niowave has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include SBIR and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States |
Investor details for Niowave
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Niowave
4 people are tracked at Niowave (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Mike Zamiara | CEO | Leadership |
Ryan Jankovic | Director Of Finance And Business Development | Leadership |
Jerry Hollister | Director Of Government Contracts / Chief Operating Officer | Leadership |
Jaime Lerma | Controller | Team |
Complete people profiles for Niowave
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Niowave
3 dated milestones of Niowave across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Niowave is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $1.9M.
Competitors of Niowave
Niowave has 3 listed competitors in our database, 2 of them funded. They include NorthStar Medical Radioisotopes, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| northstarnm.com | 2006 | Madison, United States | $15.09M | Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market | ||
| gfpharma.com | 2012 | Lincoln, United States | Proprietary chemistry for pharmaceutical synthesis is developed by the company. | |||
| atomicalchemy.us | 2017 | Idaho Falls, United States | $150,000 | Limited information available |
Detailed competitors of Niowave
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Niowave
The website of Niowave (niowaveinc.com) receives about 2K visits a month.
- Monthly visits2K
▲ 93.3% vs previous month
Websites whose visitors overlap most with Niowave. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
juken-gyakuten.com | juken-gyakuten.com | 100% | – | ||
toumeikobo.com | toumeikobo.com | 98% | #8,727,512 | – | |
hotaru-museum.jp | hotaru-museum.jp | 98% | #7,740,608 | – | |
poroni.com | poroni.com | 82% | – | ||
chart-institute.jp | chart-institute.jp | 80% | #7,164,019 | – |
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as Niowave (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Niowave
Complete news archive for Niowave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niowave
Niowave was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Niowave is headquartered in United States.
Mike Zamiara is the CEO of Niowave, as recorded in our data.
Niowave is a funded company, having raised a total of $9.95M across 21 funding rounds to date. The company's 1st funding round was a Grant of $200K, raised on Aug 2007.
Niowave was founded in 2006 in the United States and operates within the medical diagnostics and research sector. Superconducting electron linear accelerators, medical radioisotopes, high-power X-ray sources, and high-flux neutron sources are produced by the company. These products support nuclear imaging applications and related research activities across the industry.
Niowave's top competitors include NorthStar Medical Radioisotopes, ATOMIC ALCHEMY and Ground Fluor Pharmaceuticals.